Ming-Hsien Chan

National Yang Ming Chiao Tung University

H指数:27

被引数:2,149

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Upconversion nanoplatform unlocks the theranostic potential of Lu-177 radiotherapy via c-MET axis targeting in head and neck squamous cell carcinoma

上转换纳米平台通过靶向头颈鳞状细胞癌中的c-MET轴，解锁了Lu-177放射治疗的诊疗潜力

Materials Today Bio

IF10.2

2026-08-010

PRE

Deep neurotherapeutic strategy for ischemic stroke via focused ultrasound-enhanced delivery of curcumin-loaded antioxidant nanoliposomes

通过聚焦超声增强递送姜黄素负载抗氧化纳米脂质体的缺血性卒中深度神经治疗策略

biomater. sci.

IF0

2026-03-270

PRE

Squalene synthase induces ERα expression via cholesterol supplementation to confer statin resistance in lung cancer cells

角鲨烯合成酶通过补充胆固醇诱导ERα表达，以赋予肺癌细胞他汀耐药性。

Cancer Cell International

IF6

2026-02-130

OAAI

Nano-Enabled Broadband Near-Infrared Light Boosts Secondary Metabolite Production for Nanoliposomal Delivery toward Glioblastoma Applications

ACS Applied Nano Materials

IF5.5

2026-02-060

Gd2O3 Doped with Yb3+/Er3+ for Boosted Downshifting Pathway in NIR-IIb Region and Exploring the Dynamics of MRI/NIR-II Imaging in the Nanophosphor

Gd2O3 掺杂 Yb3+/Er3+ 以增强 NIR-IIb 区域的下转换路径，并探索纳米荧光粉中 MRI/NIR-II 成像的动力学

ACS Applied Materials & Interfaces

IF8.2

2025-10-220

Biomimetic Red Blood Cell Membrane-Coated FePt Metal-Organic Framework Nanoparticles: A Multifunctional Theranostic System for Enhanced MRI and Targeted Therapy

仿生红细胞膜包覆的FePt金属-有机框架纳米粒子：一种用于增强MRI和靶向治疗的多功能诊疗系统

Nanoscale

IF5.1

2025-08-280

OAAI

Magnetically Guided Theranostics: Novel Nanotubular Magnetic Resonance Imaging Contrast System Using Halloysite Nanotubes Embedded with Iron-Platinum Nanoparticles for Hepatocellular Carcinoma Treatment

SMALL STRUCTURES

IF11.3

2024-06-170

OAAI

PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression

CELL COMMUNICATION AND SIGNALING

IF8.9

2024-05-132

OAAI

Recent advances in near-infrared I/II persistent luminescent nanoparticles for biosensing and bioimaging in cancer analysis

ANALYTICAL AND BIOANALYTICAL CHEMISTRY

IF3.8

2024-04-0910

OAAI

ALDOC as an indicator of HMGB1 blockade combined with checkpoint inhibitor based immunotherapy in GBM patients

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Enhancing radiotherapy with lenvatinib by targeting the CXCL13/CXCR5/NF-KB axis

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Comprehensive Neurotoxicity of Lead Halide Perovskite Nanocrystals in Nematode Caenorhabditis elegans

SMALL

IF12.1

2023-09-034

Detecting intragenic trans-splicing events from non-co-linearly spliced junctions by hybrid sequencing

NUCLEIC ACIDS RESEARCH

IF13.1

2023-07-272

OAAI

Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression

CANCER LETTERS

IF10.1

2023-06-0124

PRE

Near-Infrared I/II Nanophosphors with Cr3+/Ni2+ Energy Transfer for Bioimaging

用于生物成像的具有Cr3 /Ni2能量转移的近红外I/II纳米磷光体

ADVANCED OPTICAL MATERIALS

IF7.2

2023-05-0227

PRE

CHST11 mediated SEMA7A expression contributes to TKI resistant in lung cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

ALDOC interplays with KIAA1409 to reduce m6A modifications and cancer-associated fibroblast characteristics in gliomas

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Novel MRI contrast system using halloysite nanotubes embedded with iron-platinum nanoparticles for the regulation of the CHST11 expression for cancer treatment

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Tunable single-atom nanozyme catalytic system for biological applications of therapy and diagnosis

可调单原子纳米酶催化体系在生物治疗和诊断中的应用

MATERIALS TODAY ADVANCES

IF8

2023-03-0117

OAAI

Overexpression of synaptic vesicle protein Rab GTPase 3C promotes vesicular exocytosis and drug resistance in colorectal cancer cells

MOLECULAR ONCOLOGY

IF4.5

2023-02-146

Ming-Hsien Chan

个人简介

教育背景

工作经历

荣誉奖项

研究方向